Company Filing History:
Years Active: 2012-2024
Title: Innovations of Chenguang Zhao in Thromboembolic Treatment
Introduction
Chenguang Zhao is a prominent inventor based in San Diego, CA, known for his significant contributions to the field of pharmaceuticals. He holds 5 patents that focus on innovative compounds and methods aimed at modulating factors related to thromboembolic conditions. His work has the potential to greatly impact the treatment and prevention of serious health issues.
Latest Patents
One of Chenguang Zhao's latest patents involves compounds and methods for modulating factor XII. This patent provides compounds, methods, and pharmaceutical compositions designed to reduce the amount or activity of FXII RNA in a cell or subject. These innovations are particularly useful in preventing, treating, or ameliorating symptoms associated with thromboembolic conditions such as deep vein thrombosis, pulmonary embolism, myocardial infarction, and stroke. Symptoms addressed by these compounds include pain, shortness of breath, and fatigue, among others. Another significant patent focuses on the modulation of factor 11 expression. This patent discloses antisense compounds and methods aimed at decreasing Factor 11, which can help treat or prevent thromboembolic complications. The administration of these antisense compounds can be crucial for individuals at risk for thrombosis and embolism.
Career Highlights
Chenguang Zhao has worked with notable companies in the pharmaceutical industry, including Isis Pharmaceuticals, Inc. and Ionis Pharmaceuticals, Inc. His experience in these organizations has contributed to his expertise in developing innovative treatments for thromboembolic conditions.
Collaborations
Chenguang has collaborated with several professionals in his field, including Jeffrey R. Crosby and Susan M. Freier. These collaborations have likely enhanced the development and application of his innovative patents.
Conclusion
Chenguang Zhao's work in the pharmaceutical industry showcases his dedication to advancing treatments for thromboembolic conditions. His innovative patents and collaborations highlight his significant contributions to medical science.